BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 31188051)

  • 1. Metabolic Syndrome Components and Long-Term Incidence of Cardiovascular Disease in Eastern Mediterranean Region: A 13-Year Population-Based Cohort Study.
    Mansourian M; Babahajiani M; Jafari-Koshki T; Roohafza H; Sadeghi M; Sarrafzadegan N
    Metab Syndr Relat Disord; 2019 Sep; 17(7):362-366. PubMed ID: 31188051
    [No Abstract]   [Full Text] [Related]  

  • 2. Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study.
    Ramezankhani A; Azizi F; Hadaegh F
    Cardiovasc Diabetol; 2022 Nov; 21(1):227. PubMed ID: 36324143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the impact of metabolic syndrome on cardiovascular events vary by using different definitions?
    Khosravi-Boroujeni H; Ahmed F; Sadeghi M; Roohafza H; Talaei M; Dianatkhah M; Pourmogaddas A; Sarrafzadegan N
    BMC Public Health; 2015 Dec; 15():1313. PubMed ID: 26715355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
    Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C;
    Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of Incident Metabolic Syndrome in a Middle Eastern Population: Isfahan Cohort Study.
    Hosseini N; Talaei M; Dianatkhah M; Sadeghi M; Oveisgharan S; Sarrafzadegan N
    Metab Syndr Relat Disord; 2017 Sep; 15(7):354-362. PubMed ID: 28677982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic disorders increase the risk to incident cardiovascular disease in middle-aged and elderly Chinese.
    Zhang ML; Hou XH; Zhu YX; Lu JX; Peng LP; Gu HL; Jia WP
    Biomed Environ Sci; 2012 Feb; 25(1):38-45. PubMed ID: 22424625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of blood pressure and other components of the metabolic syndrome on the development of cardiovascular disease.
    Kang G; Guo L; Guo Z; Hu X; Wu M; Zhou Z; Zhou H; Liu S; Chen F
    Circ J; 2010 Mar; 74(3):456-61. PubMed ID: 20057161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study.
    McNeill AM; Katz R; Girman CJ; Rosamond WD; Wagenknecht LE; Barzilay JI; Tracy RP; Savage PJ; Jackson SA
    J Am Geriatr Soc; 2006 Sep; 54(9):1317-24. PubMed ID: 16970637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.
    Hadaegh F; Shafiee G; Ghasemi A; Sarbakhsh P; Azizi F
    Diabetes Res Clin Pract; 2010 Mar; 87(3):342-7. PubMed ID: 20004035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clustering of cardio metabolic risk factors in Iranian adult population: A growing problem in the north of Iran.
    Hajian-Tilaki K; Heidari B; Firouzjahi AR
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S277-S281. PubMed ID: 28420579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular Health Status and Metabolic Syndrome in Adults Living in a Transition European Country: Findings from a Population-Based Study.
    Stojisavljević D; Janković J; Erić M; Marinković J; Janković S
    J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):568-574. PubMed ID: 29097061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of, risk factors for, and target organ damage from metabolic syndrome among people living with HIV on ART: A cross-sectional analysis in Chongqing, China.
    Liu M; He K; Wu Y; Yu Q; Sun N; Teng X; Meng X; Yuan J; Yang H
    HIV Med; 2024 May; 25(5):529-539. PubMed ID: 38158594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome and incident cardiovascular morbidity and mortality in a Mediterranean hypertensive population.
    Andreadis EA; Tsourous GI; Tzavara CK; Georgiopoulos DX; Katsanou PM; Marakomichelakis GE; Diamantopoulos EJ
    Am J Hypertens; 2007 May; 20(5):558-64. PubMed ID: 17485022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of metabolic syndrome and its determinants among Iranian adults: evidence of IraPEN survey on a bi-ethnic population.
    Jahangiry L; Khosravi-Far L; Sarbakhsh P; Kousha A; EntezarMahdi R; Ponnet K
    Sci Rep; 2019 May; 9(1):7937. PubMed ID: 31138853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in Serum Free Thyroxine Concentration Within the Reference Range Predicts the Incidence of Metabolic Syndrome in Non-Obese Adults: A Cohort Study.
    Mehran L; Amouzegar A; Bakhtiyari M; Mansournia MA; Rahimabad PK; Tohidi M; Azizi F
    Thyroid; 2017 Jul; 27(7):886-893. PubMed ID: 28486021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of expression of selenoprotein P in mRNA and protein levels with metabolic syndrome in subjects with cardiovascular disease: Results of the Selenegene study.
    Gharipour M; Sadeghi M; Salehi M; Behmanesh M; Khosravi E; Dianatkhah M; Haghjoo Javanmard S; Razavi R; Gharipour A
    J Gene Med; 2017 Mar; 19(3):. PubMed ID: 28190280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of dietary acid load with cardiovascular risk factors and the prevalence of metabolic syndrome in Iranian women: A cross-sectional study.
    Mozaffari H; Namazi N; Larijani B; Bellissimo N; Azadbakht L
    Nutrition; 2019; 67-68():110570. PubMed ID: 31568970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal fasting plasma glucose predicts type 2 diabetes and cardiovascular disease in elderly population in Taiwan.
    Huang CL; Chang HW; Chang JB; Chen JH; Lin JD; Wu CZ; Pei D; Hung YJ; Lee CH; Chen YL; Hsieh CH
    QJM; 2016 Aug; 109(8):515-22. PubMed ID: 26576838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.
    Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; March CE; Balbín E; Stavile RN; Reaven GM
    J Intern Med; 2013 Jun; 273(6):595-601. PubMed ID: 23331522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between metabolic syndrome and its components and cardiovascular disease in middle-aged and elderly Chinese population: a national cross-sectional survey.
    Li W; Song F; Wang X; Wang D; Chen D; Yue W; Zhang H; Wang Z; Lu Z
    BMJ Open; 2019 Aug; 9(8):e027545. PubMed ID: 31427317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.